B. Riley Securities Downgrades Bicycle Therapeutics to Neutral, Lowers Price Target to $28
B. Riley Securities Downgrades Bicycle Therapeutics to Neutral, Lowers Price Target to $28
b. Riley Securities將Bicycle Therapeutics的評級下調爲中立，將價格目標下調至28美元。
B. Riley Securities analyst Kalpit Patel downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Buy to Neutral and lowers the price target from $33 to $28.
b. Riley Securities分析師Kalpit Patel將Bicycle Therapeutics（納斯達克：BCYC）的評級從買入降爲中立，並將價格目標從33美元下調至28美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間